TP53 and malignant colon neoplasm: Co-treatment with 5-FU and apigenin also further induced P53 upregulation, ROS production, the dysregulation of calcium ion signaling, cell cycle arrest, and the depolarization of mitochondrial membrane potential in colon cancer cells [196].